[
  {
    "title": "伟思医疗(688580.SH)：截至12月底已累计回购0.47%股份",
    "href": "http://stock.jrj.com.cn/2023/01/03203437256554.shtml",
    "datetime": "2023-01-03 20:34:59",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：高管暨核心技术人员黄河、高管伍夏辞职",
    "href": "http://stock.jrj.com.cn/2022/12/30164837249958.shtml",
    "datetime": "2022-12-30 16:48:28",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)截至11月底已累计回购0.4714%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/04161637186890.shtml",
    "datetime": "2022-12-04 16:16:40",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：床边主被动康复训练系统取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/11/16153937143524.shtml",
    "datetime": "2022-11-16 15:39:31",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：磁刺激仪获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/11/10154237127581.shtml",
    "datetime": "2022-11-10 15:42:40",
    "code": "688580"
  },
  {
    "title": "伟思医疗：战略收购科瑞达激光 协同发展助力泌尿科新突破",
    "href": "http://stock.jrj.com.cn/2022/11/08220537122148.shtml",
    "datetime": "2022-11-08 22:05:44",
    "code": "688580"
  },
  {
    "title": "A股异动 | 伟思医疗(688580.SH)涨超5% 拟5880万收购科瑞达激光70%股权",
    "href": "http://stock.jrj.com.cn/2022/11/02102337105589.shtml",
    "datetime": "2022-11-02 10:23:56",
    "code": "688580"
  },
  {
    "title": "打造新业务增长点 伟思医疗拟5880万元收购科瑞达激光70%股权",
    "href": "http://stock.jrj.com.cn/2022/11/01194237104427.shtml",
    "datetime": "2022-11-01 19:42:53",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：截至10月底已累计回购32.34万股",
    "href": "http://stock.jrj.com.cn/2022/11/01171937103685.shtml",
    "datetime": "2022-11-01 17:19:54",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：拟5880万元收购科瑞达激光70%股权、进一步覆盖延伸泌尿等科室",
    "href": "http://stock.jrj.com.cn/2022/11/01171837103690.shtml",
    "datetime": "2022-11-01 17:18:35",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：第三季度净利降37.72%至2391.20万元",
    "href": "http://stock.jrj.com.cn/2022/10/30180537097576.shtml",
    "datetime": "2022-10-30 18:05:00",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：截至9月底已累计回购32.3448万股",
    "href": "http://stock.jrj.com.cn/2022/10/09161637041622.shtml",
    "datetime": "2022-10-09 16:16:02",
    "code": "688580"
  },
  {
    "title": "A股异动 | 伟思医疗跌超6% 阳和投资拟合计减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2022/09/19103737003885.shtml",
    "datetime": "2022-09-19 10:37:51",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：阳和投资方面拟合计减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2022/09/16203937001592.shtml",
    "datetime": "2022-09-16 20:39:19",
    "code": "688580"
  },
  {
    "title": "伟思医疗（688580）：举行投资者关系活动",
    "href": "http://stock.jrj.com.cn/2022/09/07091336978945.shtml",
    "datetime": "2022-09-07 09:13:23",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：减持期届满 仅股东谭飞减持12.84万股",
    "href": "http://stock.jrj.com.cn/2022/09/05161236973866.shtml",
    "datetime": "2022-09-05 16:12:42",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580)：以集中竞价交易方式回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/09/05092036972569.shtml",
    "datetime": "2022-09-05 09:20:32",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)截至8月底已累计回购32.3448万股",
    "href": "http://stock.jrj.com.cn/2022/09/04160136971911.shtml",
    "datetime": "2022-09-04 16:01:53",
    "code": "688580"
  },
  {
    "title": "伟思医疗披露2022年半年报 实现营收1.34亿元",
    "href": "http://stock.jrj.com.cn/2022/08/29092536945571.shtml",
    "datetime": "2022-08-29 09:25:10",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580)：公司证券事务代表辞职",
    "href": "http://stock.jrj.com.cn/2022/08/29092136945577.shtml",
    "datetime": "2022-08-29 09:21:17",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580)：向激励对象首次授予限制性股票",
    "href": "http://stock.jrj.com.cn/2022/08/29092036945579.shtml",
    "datetime": "2022-08-29 09:20:33",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)上半年净利3825.68万元，同比下降44.70%",
    "href": "http://stock.jrj.com.cn/2022/08/28155636944146.shtml",
    "datetime": "2022-08-28 15:56:18",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)入选国家级专精特新“小巨人”企业名单",
    "href": "http://stock.jrj.com.cn/2022/08/15173936900825.shtml",
    "datetime": "2022-08-15 17:39:05",
    "code": "688580"
  },
  {
    "title": "伟思医疗（688580）：举行投资者关系活动",
    "href": "http://stock.jrj.com.cn/2022/08/08091936877653.shtml",
    "datetime": "2022-08-08 09:19:04",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：截至7月底已累计回购32.34万股",
    "href": "http://stock.jrj.com.cn/2022/08/01155436859234.shtml",
    "datetime": "2022-08-01 15:54:18",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：取得医疗器械注册证、涉及磁刺激仪",
    "href": "http://stock.jrj.com.cn/2022/07/25185636840929.shtml",
    "datetime": "2022-07-25 18:56:38",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：截至6月底已累计回购32.34万股",
    "href": "http://stock.jrj.com.cn/2022/07/01210736776596.shtml",
    "datetime": "2022-07-01 21:07:41",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：拟推2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/06/27183436762043.shtml",
    "datetime": "2022-06-27 18:34:03",
    "code": "688580"
  },
  {
    "title": "说明项目终止的具体原因？伟思医疗回复问询函",
    "href": "http://stock.jrj.com.cn/2022/06/22114036749067.shtml",
    "datetime": "2022-06-22 11:40:17",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：拟对“康复设备组装调试项目”进行变更和延期",
    "href": "http://stock.jrj.com.cn/2022/06/21190036747275.shtml",
    "datetime": "2022-06-21 19:00:17",
    "code": "688580"
  },
  {
    "title": "上市两年 业绩走低 伟思医疗变更7880万元募资用途引上交所问询",
    "href": "http://stock.jrj.com.cn/2022/06/16090136733676.shtml",
    "datetime": "2022-06-16 09:01:00",
    "code": "688580"
  },
  {
    "title": "伟思医疗募投项目建设有关情况收问询函",
    "href": "http://stock.jrj.com.cn/2022/06/15111836730320.shtml",
    "datetime": "2022-06-15 11:18:04",
    "code": "688580"
  },
  {
    "title": "伟思医疗拟终止康复设备组装调试项目，剩余募投资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/06/14111336726880.shtml",
    "datetime": "2022-06-14 11:13:31",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：减持期过半 仅股东谭飞减持12.84万股",
    "href": "http://stock.jrj.com.cn/2022/06/08174736712973.shtml",
    "datetime": "2022-06-08 17:47:25",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：截至5月底已累计回购32.34万股",
    "href": "http://stock.jrj.com.cn/2022/06/02154936700359.shtml",
    "datetime": "2022-06-02 15:49:15",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580)：2021年每10股派发现金红利13.01元（含税）",
    "href": "http://stock.jrj.com.cn/2022/05/26085036679723.shtml",
    "datetime": "2022-05-26 08:50:10",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)截至4月底已累计回购22.6632万股",
    "href": "http://stock.jrj.com.cn/2022/05/06175336581792.shtml",
    "datetime": "2022-05-06 17:53:12",
    "code": "688580"
  },
  {
    "title": "伟思医疗2022年第一季度净利1700.97万同比下滑45.62% 疫情影响收入下降",
    "href": "http://stock.jrj.com.cn/2022/05/03193236546570.shtml",
    "datetime": "2022-05-03 19:32:41",
    "code": "688580"
  },
  {
    "title": "伟思医疗2021年净利1.78亿同比增长23.77% 董事长王志愚薪酬172.45万",
    "href": "http://stock.jrj.com.cn/2022/05/02173236533033.shtml",
    "datetime": "2022-05-02 17:32:46",
    "code": "688580"
  },
  {
    "title": "伟思医疗披露2022年一季报 实现营收5410.73万元",
    "href": "http://stock.jrj.com.cn/2022/04/28091636490578.shtml",
    "datetime": "2022-04-28 09:16:46",
    "code": "688580"
  },
  {
    "title": "伟思医疗披露2021年年报 实现营收4.30亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28091636490580.shtml",
    "datetime": "2022-04-28 09:16:22",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：一季度净利润降45.62%至1700.97万元",
    "href": "http://stock.jrj.com.cn/2022/04/27204936486344.shtml",
    "datetime": "2022-04-27 20:49:01",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：2021年净利增23.77%至1.78亿元 拟10派13.01元",
    "href": "http://stock.jrj.com.cn/2022/04/27204736486347.shtml",
    "datetime": "2022-04-27 20:47:22",
    "code": "688580"
  },
  {
    "title": "伟思医疗将花不超4000万元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2022/04/11225236309439.shtml",
    "datetime": "2022-04-11 22:52:02",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：拟斥2000万元-4000万元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/04/11174236305386.shtml",
    "datetime": "2022-04-11 17:42:05",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：拟使用不超8亿元闲置自有资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2022/04/06185436263889.shtml",
    "datetime": "2022-04-06 18:54:37",
    "code": "688580"
  },
  {
    "title": "麦澜德75%核心技术人员出自伟思医疗，董事长未辞职先创业，与前东家专利官司曾打到最高法院",
    "href": "http://stock.jrj.com.cn/2022/03/10151534808575.shtml",
    "datetime": "2022-03-10 15:15:16",
    "code": "688580"
  },
  {
    "title": "A股异动 | 伟思医疗跌5% 阳和投资及一致行动人拟减持不超3.97%股份",
    "href": "http://stock.jrj.com.cn/2022/02/16100934364590.shtml",
    "datetime": "2022-02-16 10:09:10",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：阳和投资及其一致行动人拟合计减持不超3.97%股份",
    "href": "http://stock.jrj.com.cn/2022/02/15160334353795.shtml",
    "datetime": "2022-02-15 16:03:24",
    "code": "688580"
  },
  {
    "title": "伟思医疗股东及其一致行动人合计减持58.81万股 套现5962.61万 2021年公司净利1.78亿",
    "href": "http://stock.jrj.com.cn/2022/02/11195234324719.shtml",
    "datetime": "2022-02-11 19:52:56",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：减持期届满 阳和投资及其行动人已减持0.86%股份",
    "href": "http://stock.jrj.com.cn/2022/02/11154934323514.shtml",
    "datetime": "2022-02-11 15:49:59",
    "code": "688580"
  },
  {
    "title": "伟思医疗2021年净利1.78亿同比增长24% 外骨骼康复机器人实现上市销售",
    "href": "http://stock.jrj.com.cn/2022/01/21185134183743.shtml",
    "datetime": "2022-01-21 18:51:04",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)业绩快报：2021年度净利润升23.81%至1.78亿元",
    "href": "http://stock.jrj.com.cn/2022/01/21163634182751.shtml",
    "datetime": "2022-01-21 16:36:12",
    "code": "688580"
  },
  {
    "title": "伟思医疗选举王志愚为董事长 第三季度公司净利3839.19万",
    "href": "http://stock.jrj.com.cn/2021/11/12221233842924.shtml",
    "datetime": "2021-11-12 22:12:19",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：选举王志愚为董事长、聘任陈莉莉为财务总监",
    "href": "http://stock.jrj.com.cn/2021/11/12201733842456.shtml",
    "datetime": "2021-11-12 20:17:07",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：向2名激励对象授予0.90万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/11/12201533842448.shtml",
    "datetime": "2021-11-12 20:15:06",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：减持期过半 仅阳和投资、连庆明减持合计15.23万股",
    "href": "http://stock.jrj.com.cn/2021/11/12184533842042.shtml",
    "datetime": "2021-11-12 18:45:24",
    "code": "688580"
  },
  {
    "title": "和佳医疗：前三季度净利预降90%-100% 来自伟思医疗的投资收益大幅下降",
    "href": "http://stock.jrj.com.cn/2021/10/22215833735719.shtml",
    "datetime": "2021-10-22 21:58:50",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/08/01151233180557.shtml",
    "datetime": "2021-08-01 15:12:36",
    "code": "688580"
  },
  {
    "title": "伟思医疗2021年上半年净利6918.16万增长28.99% 磁刺激类产品销售收入增长",
    "href": "http://stock.jrj.com.cn/2021/07/27204533159694.shtml",
    "datetime": "2021-07-27 20:45:47",
    "code": "688580"
  },
  {
    "title": "伟思医疗：上半年营收净利双增长 经营性现金流同比增三倍",
    "href": "http://stock.jrj.com.cn/2021/07/27193633159469.shtml",
    "datetime": "2021-07-27 19:36:08",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)上半年不考虑股份支付费用影响纯利升44.33% 研发投入大增84.21% 经营现金流升329.87%",
    "href": "http://stock.jrj.com.cn/2021/07/27173333158792.shtml",
    "datetime": "2021-07-27 17:33:53",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：半年度净利升28.99%至6918.16万元",
    "href": "http://stock.jrj.com.cn/2021/07/27171633158714.shtml",
    "datetime": "2021-07-27 17:16:14",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：股东阳和投资及其一致行动人拟减持不超3.65%股份",
    "href": "http://stock.jrj.com.cn/2021/07/21174633130605.shtml",
    "datetime": "2021-07-21 17:46:23",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：控股子公司下肢步行外骨骼辅助训练装置取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/06/30170133022204.shtml",
    "datetime": "2021-06-30 17:01:58",
    "code": "688580"
  },
  {
    "title": "伟思医疗：TT公司将其拥有的MyOnyx设备技术转让给公司 交易价格约2860万元",
    "href": "http://stock.jrj.com.cn/2021/06/11131932910609.shtml",
    "datetime": "2021-06-11 13:19:23",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：斥600万加元获MyOnyx设备技术在中国大陆所有权利",
    "href": "http://stock.jrj.com.cn/2021/06/10175132906127.shtml",
    "datetime": "2021-06-10 17:51:12",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：2020年度拟10派10.51元 5月21日股权登记",
    "href": "http://stock.jrj.com.cn/2021/05/14170032755697.shtml",
    "datetime": "2021-05-14 17:00:52",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：一季度净利升84.17%至3128.19万元",
    "href": "http://stock.jrj.com.cn/2021/04/27220632465870.shtml",
    "datetime": "2021-04-27 22:06:01",
    "code": "688580"
  },
  {
    "title": "伟思医疗盈利1.44亿五成用于分红 康复医疗市场增长核心产品产销齐升",
    "href": "http://stock.jrj.com.cn/2021/04/09073232338934.shtml",
    "datetime": "2021-04-09 07:32:39",
    "code": "688580"
  },
  {
    "title": "伟思医疗拟每10股派10.51元 派现比例为50%",
    "href": "http://stock.jrj.com.cn/2021/04/08104932330749.shtml",
    "datetime": "2021-04-08 10:49:50",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：2020年度净利升44.07%至1.44亿元 拟10派10.51元",
    "href": "http://stock.jrj.com.cn/2021/04/07184632326528.shtml",
    "datetime": "2021-04-07 18:46:01",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)拟以1.79亿元超募资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/04/07184132326494.shtml",
    "datetime": "2021-04-07 18:41:49",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)向100名激励对象授予85.85万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/03/15190832138089.shtml",
    "datetime": "2021-03-15 19:08:17",
    "code": "688580"
  },
  {
    "title": "伟思医疗跌5% 市值80亿去年净利1.4亿元",
    "href": "http://stock.jrj.com.cn/2021/03/03181232064707.shtml",
    "datetime": "2021-03-03 18:12:00",
    "code": "688580"
  },
  {
    "title": "伟思医疗2020年度净利1.44亿增长44% 磁刺激类产品收入增长",
    "href": "http://stock.jrj.com.cn/2021/02/24184532019995.shtml",
    "datetime": "2021-02-24 18:45:55",
    "code": "688580"
  },
  {
    "title": "伟思医疗：持续深耕康复医疗器械领域 今年初披露涉百人股权激励方案",
    "href": "http://stock.jrj.com.cn/2021/02/23182132013538.shtml",
    "datetime": "2021-02-23 18:21:13",
    "code": "688580"
  },
  {
    "title": "A股异动 | 伟思医疗(688580.SH)大涨超14% 绩后获券商唱好",
    "href": "http://stock.jrj.com.cn/2021/02/23095132010813.shtml",
    "datetime": "2021-02-23 09:51:31",
    "code": "688580"
  },
  {
    "title": "伟思医疗：2020年盈利增长44.07%至1.44亿元",
    "href": "http://stock.jrj.com.cn/2021/02/23093132010705.shtml",
    "datetime": "2021-02-23 09:31:19",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)业绩快报：2020年度净利升44.07%至1.44亿元",
    "href": "http://stock.jrj.com.cn/2021/02/22170432006542.shtml",
    "datetime": "2021-02-22 17:04:27",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：约72.76万股限售股1月21日解禁",
    "href": "http://stock.jrj.com.cn/2021/01/12163931676953.shtml",
    "datetime": "2021-01-12 16:39:19",
    "code": "688580"
  },
  {
    "title": "伟思医疗持续深耕康复医疗器械领域 拟投资5亿元打造总部研发经济园",
    "href": "http://stock.jrj.com.cn/2020/12/15204131496559.shtml",
    "datetime": "2020-12-15 20:41:35",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：拟投资5亿元打造伟思医疗总部研发经济园项目",
    "href": "http://stock.jrj.com.cn/2020/12/15182131495630.shtml",
    "datetime": "2020-12-15 18:21:15",
    "code": "688580"
  },
  {
    "title": "伟思医疗(688580.SH)：拟变更经营范围",
    "href": "http://stock.jrj.com.cn/2020/12/15181431495598.shtml",
    "datetime": "2020-12-15 18:14:20",
    "code": "688580"
  },
  {
    "title": "伟思医疗：公司实现营业收入255,077,629.95元",
    "href": "http://stock.jrj.com.cn/2020/11/06094531228605.shtml",
    "datetime": "2020-11-06 09:45:54",
    "code": "688580"
  },
  {
    "title": "伟思医疗：保持较高的盈利能力和市场占有率",
    "href": "http://stock.jrj.com.cn/2020/11/06094531228604.shtml",
    "datetime": "2020-11-06 09:45:52",
    "code": "688580"
  },
  {
    "title": "伟思医疗跌19.49% 易方达等公募基金与海通证券均持股",
    "href": "http://stock.jrj.com.cn/2020/10/29173931158510.shtml",
    "datetime": "2020-10-29 17:39:00",
    "code": "688580"
  },
  {
    "title": "[伟思医疗]蓬勃伟思 绚丽绽放",
    "href": "http://stock.jrj.com.cn/2020/10/26000031133939.shtml",
    "datetime": "2020-10-26 00:00:00",
    "code": "688580"
  },
  {
    "title": "[伟思医疗]蓬勃伟思 绚丽绽放 伟思医疗亮相第83届中国国际医疗器械博览会",
    "href": "http://stock.jrj.com.cn/2020/10/26000031135777.shtml",
    "datetime": "2020-10-26 00:00:00",
    "code": "688580"
  },
  {
    "title": "伟思医疗上市首日涨167%换手率7成 比预期多募近6亿",
    "href": "http://stock.jrj.com.cn/2020/07/21160730304855.shtml",
    "datetime": "2020-07-21 16:07:00",
    "code": "688580"
  },
  {
    "title": "研发若落伍 伟思医疗会不会“抑郁”？",
    "href": "http://stock.jrj.com.cn/2020/07/10004430195537.shtml",
    "datetime": "2020-07-10 00:44:12",
    "code": "688580"
  },
  {
    "title": "【兑奖啦】科创板伟思医疗网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/09191330193966.shtml",
    "datetime": "2020-07-09 19:13:57",
    "code": "688580"
  },
  {
    "title": "【兑奖啦】科创板寒武纪、伟思医疗网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/09191230193963.shtml",
    "datetime": "2020-07-09 19:12:27",
    "code": "688580"
  },
  {
    "title": "伟思医疗网上发行最终中签率为0.0349%",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/09080330187316.shtml",
    "datetime": "2020-07-09 08:03:38",
    "code": "688580"
  },
  {
    "title": "伟思医疗：网上发行最终中签率为0.03485421％",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/08192330181808.shtml",
    "datetime": "2020-07-08 19:23:09",
    "code": "688580"
  },
  {
    "title": "和佳医疗：参股公司投资的伟思医疗在科创板上市发行",
    "href": "http://stock.jrj.com.cn/2020/07/08185930181654.shtml",
    "datetime": "2020-07-08 18:59:43",
    "code": "688580"
  },
  {
    "title": "今日新股申购：寒武纪、伟思医疗、美瑞新材",
    "href": "http://stock.jrj.com.cn/2020/07/08090130175715.shtml",
    "datetime": "2020-07-08 09:01:00",
    "code": "688580"
  },
  {
    "title": "伟思医疗今日申购 顶格申购需配市值4.5万元",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/08080130175755.shtml",
    "datetime": "2020-07-08 08:01:39",
    "code": "688580"
  },
  {
    "title": "科创板新股伟思医疗、寒武纪7月8日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/07150730167126.shtml",
    "datetime": "2020-07-07 15:07:59",
    "code": "688580"
  },
  {
    "title": "康复医疗稀缺标的还是“重销售轻研发”？ 伟思医疗即将登陆科创板 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/07/03190330135998.shtml",
    "datetime": "2020-07-03 19:03:33",
    "code": "688580"
  },
  {
    "title": "伟思医疗过会：今年科创板过会第37家 长江保荐过首单",
    "href": "http://stock.jrj.com.cn/2020/05/27142129778584.shtml",
    "datetime": "2020-05-27 14:21:00",
    "code": "688580"
  },
  {
    "title": "前员工“另起炉灶”造同城“劲敌” 伟思医疗招股书牵出专利权大战",
    "href": "http://stock.jrj.com.cn/2019/12/24203528580902.shtml",
    "datetime": "2019-12-24 20:35:05",
    "code": "688580"
  },
  {
    "title": "伟思医疗上半年大客户突变 前五大中三家无社保记录",
    "href": "http://stock.jrj.com.cn/2019/12/24202328580879.shtml",
    "datetime": "2019-12-24 20:23:21",
    "code": "688580"
  },
  {
    "title": "伟思医疗2019年上半年大客户突变 前五大中三家无社保记录",
    "href": "http://stock.jrj.com.cn/2019/12/24200628580836.shtml",
    "datetime": "2019-12-24 20:06:39",
    "code": "688580"
  },
  {
    "title": "伟思医疗2016年上半年营收4011万元 净赚1319万元",
    "href": "http://stock.jrj.com.cn/2016/08/24150321363137.shtml",
    "datetime": "2016-08-24 15:03:00",
    "code": "688580"
  },
  {
    "title": "伟思医疗2015年营收8050万元 净利润增长29%",
    "href": "http://stock.jrj.com.cn/2016/05/24142820994540.shtml",
    "datetime": "2016-05-24 14:28:00",
    "code": "688580"
  },
  {
    "title": "伟思医疗新三板挂牌上市 获得BFE国内独家合作权",
    "href": "http://stock.jrj.com.cn/2016/03/22091220721195.shtml",
    "datetime": "2016-03-22 09:12:00",
    "code": "688580"
  }
]